Catalys Pacific
Catalys Pacific's Overview
Catalys Pacific is an independent venture capital firm that partners with visionary entrepreneurs to build innovative life sciences companies. Focusing on early-stage investments in biotherapeutics, MedTech, and diagnostics, Catalys Pacific primarily invests in opportunities in Japan and the United States. The firm aims to bridge the innovation ecosystems of these two countries, leveraging its deep expertise and extensive networks to help create global healthcare solutions and address significant unmet medical needs.
Where is Catalys Pacific's Headquarters?
HQ Function
The Tokyo headquarters serves as the central hub for investment origination and execution in Asia, portfolio management, strategic partnerships, and overall firm operations in Japan.
Notable Features:
Located within the Nihonbashi Life Science Building complex, a prominent center for life science innovation in Tokyo, providing access to a rich ecosystem of research institutions, pharmaceutical companies, and startups.
Work Culture:
A highly collaborative, scientifically rigorous, and globally-minded work environment. The culture emphasizes deep due diligence, hands-on support for portfolio companies, and fostering cross-border innovation.
HQ Significance:
The Tokyo headquarters is pivotal for Catalys Pacific's strategy of identifying and nurturing Japanese life science innovations with global potential, and for connecting international companies to the Japanese market.
Values Reflected in HQ: The headquarters' location and function reflect Catalys Pacific's core values of innovation, scientific excellence, global collaboration, and a commitment to advancing healthcare.
Location:
Catalys Pacific operates with a significant global focus, primarily bridging the life science ecosystems of Japan and the United States. Its functions supported globally include cross-border investment sourcing and execution, international business development for portfolio companies, facilitation of global clinical trials, and strategic advisory for market entry into key regions, particularly Japan and the US.
Street Address:
Nihonbashi Life Science Building 3, 8F, 2-3-11 Nihonbashi-honcho, Chuo-ku
City:
Tokyo
State/Province:
Tokyo
Country:
Japan
Catalys Pacific's Global Presence
San Francisco Bay Area, California, USA
Address: Specific street address not publicly listed; maintains a strategic presence in the San Francisco Bay Area.
To identify and invest in promising early-stage biotherapeutics and MedTech companies in the U.S., particularly on the West Coast, and to support portfolio companies' global expansion strategies, including entry into the Japanese market.
Buying Intent Signals for Catalys Pacific
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Catalys Pacific
As of April 2025, Catalys Pacific' leadership includes:
Investors of Catalys Pacific
Catalys Pacific has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
In the past 12 months, Catalys Pacific has notably expanded its expertise by welcoming a new Venture Partner. There have been no publicly announced executive departures during this period.
New Appointments:
Technology (Tech Stack) used by Catalys Pacific
Discover the tools Catalys Pacific uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Catalys Pacific Email Formats and Examples
Catalys Pacific's email addresses are believed to commonly follow the [first initial][last name]@catalyspacific.com pattern. For general inquiries, they also provide an info@catalyspacific.com address on their website.
[first_initial][last]@catalyspacific.com
Format
bslingsby@catalyspacific.com
Example
80%
Success rate
News and media
Catalys Pacific Website • March 19, 2024
Catalys Pacific Portfolio Company ARCALIS Co., Ltd. Lists on Tokyo Stock Exchange Growth Market
ARCALIS Co., Ltd., an mRNA contract development and manufacturing organization (CDMO) and a portfolio company of Catalys Pacific, successfully completed its Initial Public Offering (IPO) and listed on the Growth Market of the Tokyo Stock Exchange....more
PR Newswire • November 1, 2023
Catalys Pacific Welcomes Megumi Kiyozuka as Venture Partner
Catalys Pacific announced that Megumi Kiyozuka joined the firm as a Venture Partner. Mr. Kiyozuka brings over two decades of experience in life science investment, venture capital, and business development globally....more
Catalys Pacific Website • October 5, 2022
Catalys Pacific Announces JPY 10B First Close of Catalys Pacific Fund II
Catalys Pacific announced the JPY 10B (approx. USD 74M) first close of Catalys Pacific Fund II. Anchor investors including Eisai Co., Ltd. are participating in the fund, which will focus on creating and building companies to deliver transformational new medicines....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Catalys Pacific, are just a search away.